Biocartesian
YC S24San Francisco, US · Founded 2023 · 2 employees · 1 known investors
Biocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.
AI & Machine LearningBiotechDeep TechHealthtechHard TechB2BDiagnosticsDrug discoveryin /biocartesian@ycombinator
Founders & leadership· Y Combinator alumni (S24)
Ian DardaniinFounder
